Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Niemann-Pick disease.

M Elleder1

  • 11st Hlava's Institute of Pathology, Faculty of Medicine, Prague, CSSR.

Pathology, Research and Practice
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Niemann-Pick disease exhibits biochemical heterogeneity, with two main types: sphingomyelinase deficiency (types A/B) and cholesterol transport defects (types C/D). Diagnosis is aided by clinical and histochemical features.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prenatal diagnosis of lysosomal enzymopathies in the Czech Republic].

Casopis lekaru ceskych·2012
Same author

[The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis].

Vnitrni lekarstvi·2012
Same author

Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency.

Gene·2012
Same author

Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone.

Clinical nephrology·2010
Same author

Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis.

Human molecular genetics·2010
Same author

Oligodendroglia from ADSL-deficient patient produce SAICAribotide and SAMP.

Molecular genetics and metabolism·2010
Same journal

Taraxerol targets the HIF1A-NEK6 axis to block TDE-mediated M2 macrophage polarization and inhibits NSCLC progression.

Pathology, research and practice·2026
Same journal

Tanshinone IIA promotes mitophagy by inhibiting the MARCHF5-mediated ubiquitination and degradation of FUNDC1 to alleviate spinal cord injury.

Pathology, research and practice·2026
Same journal

Rewiring lipid metabolism in diabetic kidney disease: Pathogenic networks and the therapeutic convergence of natural products.

Pathology, research and practice·2026
Same journal

Transcranial direct current stimulation improves cerebral ischemiareperfusion injury by regulating microglial ferroptosis and M1 polarization via KLF4/xCT.

Pathology, research and practice·2026
Same journal

Eicosanoids and flavonoids in asthma: Bridging inflammatory pathways and therapeutic potential.

Pathology, research and practice·2026
Same journal

Dimethylglycine accelerate atherosclerosis by mediating macrophages ferroptosis via NRF2 pathway suppression.

Pathology, research and practice·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Niemann-Pick disease (NPD) is a group of rare, inherited metabolic disorders.
  • Previous classifications recognized distinct types, but recent research highlights biochemical heterogeneity.
  • Understanding these biochemical differences is crucial for accurate diagnosis and potential therapeutic strategies.

Purpose of the Study:

  • To delineate the biochemical distinctions within the Niemann-Pick disease complex.
  • To differentiate between sphingomyelinase deficiency and cholesterol transport defects.
  • To explore diagnostic approaches based on biochemical and histochemical findings.

Main Methods:

  • Biochemical analysis of lysosomal enzymes and lipid storage patterns.
  • Histochemical examination of affected cell populations.

Related Experiment Videos

  • In vivo sphingomyelin degradation tests.
  • Assessment of cholesterol esterification rates.

    • Main Results:

    • Two distinct metabolic disorders identified: Niemann-Pick sphingomyelinosis (lysosomal sphingomyelinase deficiency) and NPD types C-D (cholesterol transport defects).
    • Niemann-Pick sphingomyelinosis presents allelic variants (neuronopathic A and visceral B) distinguishable by sphingomyelin levels.
    • NPD types C-D show heterogeneous lipid storage and impaired intracellular cholesterol transport, with secondary sphingomyelinase activity changes.
    • Lactosylceramidosis is identified as a rare variant within the C-D group.

    Conclusions:

    • Niemann-Pick disease is biochemically heterogeneous, comprising distinct sphingomyelinase deficiency and cholesterol transport disorders.
    • Clinical and histochemical features provide efficient diagnostic markers at the clinicopathological level.
    • Further research is needed to clarify the biochemical basis of Niemann-Pick disease type E.